GlassScriptPhysician profile
Isam Daboul
NPI 1306820618
$76,334.07
in general payments reported to CMS, 2019-2025
29 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $5,259 · 2022: $12K · 2023: $11K · 2024: $12K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $5,806 · Food and Beverage: $2,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,060.00 |
| Travel and Lodging | $5,805.97 |
| Food and Beverage | $2,961.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $71,608.39 | 2019-2025 | Epclusa, Livdelzi |
| Boston Scientific Corporation | $1,814.70 | 2022-2025 | General - Pain Management, Spyglass, X-Tack Endoscopic Helix Tacking System |
| Abbvie INC. | $506.43 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Novo Nordisk INC | $332.65 | 2019-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $255.26 | 2019-2022 | |
| Medtronic, INC. | $137.00 | 2022 | |
| Pfizer INC. | $133.24 | 2019 | |
| Sunovion Pharmaceuticals INC. | $124.62 | 2019 | |
| Redhill Biopharma INC. | $119.37 | 2021 | |
| Allergan, INC. | $117.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.16 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $111.77 | 2025 | Iqirvo |
| Amarin Pharma, INC. | $110.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $108.27 | 2025 | |
| Nestle Healthcare Nutrition INC. | $92.97 | 2021-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $88.80 | 2024 | |
| Integra Lifesciences Corporation | $87.52 | 2024 | Medihoney, Biodfactor, Biodrestore |
| E.R. Squibb & Sons, L.L.C. | $77.98 | 2022 | |
| Janssen Scientific Affairs, LLC | $68.15 | 2022 | |
| Ambu INC. | $57.30 | 2020-2025 | |
| Lifenet Health | $55.55 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Depuy Synthes Sales INC. | $54.03 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.60 | 2022-2023 | Entyvio |
| Janssen Biotech, INC. | $23.14 | 2022 | |
| Aimmune Therapeutics, INC. | $22.10 | 2025 | Vowst |
| Tersera Therapeutics LLC | $20.81 | 2023 | Xermelo |
| Merck Sharp & Dohme LLC | $18.28 | 2022 | |
| Olympus America INC. | $13.47 | 2019 | |
| Endogastric Solutions, INC | $7.90 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isam Daboul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.